Disc Medicine (IRON) Current Leases (2021 - 2026)
Disc Medicine (IRON) reported Current Leases of $419000.0 for Q1 2026, down 12.53% year-over-year from $479000.0 in Q1 2025, and down 31.42% quarter-over-quarter from $611000.0 in Q4 2025.
Disc Medicine (IRON) Current Leases (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Current Leases data on file, last reported at $419000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $419000.0, down 12.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $419000.0 (down 12.53% YoY), and the FY2025 annual result was $611000.0, up 370.0% from the prior year.
- Current Leases retreated to $419000.0 in Q1 2026 per IRON's latest filing, from $611000.0 in the prior quarter.
- Over five years, Current Leases peaked at $767000.0 in Q1 2024 and troughed at $76000.0 in Q3 2024.
- A 5-year average of $463428.6 and a median of $449000.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases slumped 80.45% in 2024, then soared 763.16% in 2025.
- A 5-year view of Current Leases shows it stood at $307000.0 in 2022, then soared by 116.61% to $665000.0 in 2023, then tumbled by 80.45% to $130000.0 in 2024, then soared by 370.0% to $611000.0 in 2025, then tumbled by 31.42% to $419000.0 in 2026.
- Business Quant data shows IRON's Current Leases at $419000.0 in Q1 2026, $611000.0 in Q4 2025, and $656000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Disc Medicine | 2.62 Bn | 1.89 Bn | - | 419,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 611,000.00 |
| Sep 30, 2025 | 656,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 479,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 759,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Dec 31, 2023 | 665,000.00 |
| Sep 30, 2023 | 353,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 319,000.00 |